Kevin C Lindquist (Kevin Lindquist)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 5

Top Venues

mAbs

Nature communications

Molecular cancer therapeutics

Cancer immunology research

Pfizer Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Inc Aug 24 2009

United States

Associate Research Fellow :: BioMedicine Design

Publications

Spencer Park, Edward Pascua, Kevin C Lindquist, Christopher R Kimberlin, Xiaodi Deng, Yvonne S L Mak, Zea Melton, Theodore O Johnson, Regina Lin, Bijan Boldajipour, Robert T Abraham, Jaume Pons, Barbra Johnson Sasu, Thomas J Van Blarcom, Javier Chaparro-Riggers
Direct control of CAR T cells through small molecule-regulated antibodies. Nature communications 12 (1) (2021)
Wei Chen, Fan Yang, Carole Wang, Jatin Narula, Edward Pascua, Irene Ni, Sheng Ding, Xiaodi Deng, Matthew Ling-Hon Chu, Amber Pham, Xiaoyue Jiang, Kevin C Lindquist, Patrick J Doonan, Tom Van Blarcom, Yik Andy Yeung, Javier Chaparro-Riggers
One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeutics. mAbs 13 (1) (2021)
Yuanming Xu, Lucia Campos Carrascosa, Yik Andy Yeung, Matthew Ling-Hon Chu, Wenjing Yang, Ivana Djuretic, Danielle C Pappas, John Zeytounian, Zhouhong Ge, Valeska de Ruiter, Gabriel R Starbeck-Miller, James Patterson, Diamanda Rigas, Shih-Hsun Chen, Eugenia Kraynov, Patrick P Boor, Lisanne Noordam, Michael Doukas, Dave Tsao, Jan Nicolaas Maria IJzermans, Jie Guo, Dirk J van Grünhagen, Joris Erdmann, Joanne Verheij, Martin E van Royen, Pascal G Doornebosch, Renny Feldman, Terrence Park, Salah Mahmoudi, Magdalena Dorywalska, Irene Ni, Sherman M Chin, Tina Mistry, Lidia Mosyak, Laura Lin, Keith A Ching, Kevin C Lindquist, Changhua Ji, Luz Marina Londono, Bing Kuang, Robert Rickert, Jaap Kwekkeboom, Dave Sprengers, Tzu-Hsuan Huang, Javier Chaparro-Riggers
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity. Cancer immunology research 9 (10) (2021)
Siler H Panowski, Tracy C Kuo, Yi Zhang, Amy Chen, Tao Geng, Laura Aschenbrenner, Cris Kamperschroer, Edward Pascua, Wei Chen, Kathy Delaria, Santiago Farias, Marjorie Bateman, Russell G Dushin, Sherman M Chin, Thomas J Van Blarcom, Yik Andy Yeung, Kevin C Lindquist, Allison G Chunyk, Bing Kuang, Bora Han, Michael Mirsky, Ingrid Pardo, Bernard Buetow, Thomas G Martin, Jeffrey L Wolf, David Shelton, Arvind Rajpal, Pavel Strop, Javier Chaparro-Riggers, Barbra J Sasu
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma. Molecular cancer therapeutics 18 (11) (2019)
Thomas Van Blarcom, Kevin C Lindquist, Zea Melton, Wai Ling Cheung, Chris Wagstrom, Dan McDonough, Cendy Valle Oseguera, Sheng Ding, Andrea Rossi, Shobha Potluri, Purnima Sundar, Steven J Pitts, Marina Sirota, Meritxell Galindo Casas, Yu Yan, Jeffrey Jones, Zygy Roe-Zurz, Surabhi Srivatsa Srinivasan, Wenwu Zhai, Jaume Pons, Arvind Rajpal, Javier Chaparro-Riggers
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies. mAbs 10 (2) (2017)

Kevin C Lindquist.css-eqlu8i{font-size:small;padding-left:4px;} (Kevin Lindquist)

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin C Lindquist (Kevin Lindquist)